Results 81 to 90 of about 10,595 (215)

Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh

open access: yesEmerging Infectious Diseases
Japanese encephalitis (JE) is preventable using the affordable, effective, and safe live attenuated SA 14-14-2 JE vaccine (CD-JEV). We used a Markov model to evaluate the cost-effectiveness of 1 dose of CD-JEV compared with no vaccination in 3 ...
An Nguyen   +10 more
doaj   +1 more source

Japanese encephalitis vaccine in travelers

open access: yesExpert Review of Vaccines, 2008
Extensive vaccination against Japanese encephalitis (JE) has been carried out in many Asian countries for the past 20 years and is also increasingly recommended for travelers to endemic areas. Concerns have been raised regarding potential neurological and allergic side effects of the currently available JE vaccine, which is manufactured from mouse ...
openaire   +2 more sources

Screening of Protective Antigens of Japanese Encephalitis Virus by DNA Immunization: a Comparative Study with Conventional Viral Vaccines [PDF]

open access: bronze, 1999
Hsin–Wei Chen   +7 more
openalex   +1 more source

The alarming spread of Japanese encephalitis: A growing public health concern

open access: yesOpen Veterinary Journal
Japanese encephalitis (JE) is a zoonotic infectious disease transmitted by mosquitoes. JE is caused by the Japanese encephalitis virus (JEV), a member of the flavivirus genus.
Anindita Riesti Retno Arimurti   +17 more
doaj   +1 more source

Prevention, diagnosis, and management of Japanese encephalitis in children

open access: yesPediatric Health, Medicine and Therapeutics, 2014
Rashmi Kumar Department of Pediatrics, King George Medical University, Lucknow (UP), India Abstract: Japanese encephalitis is the single largest cause of viral encephalitis in the world today.
Kumar R
doaj  

Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview

open access: yesHeliyon
To overcome the limitations of conventional vaccines, new platforms for vaccine design have emerged such as those based on viral vectors and virus-like particles (VLPs).
Ruth Henríquez, Isabel Muñoz-Barroso
doaj   +1 more source

Home - About - Disclaimer - Privacy